Pub. Date : 2018 Jan 31
PMID : 29386360
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma. | venetoclax | B cell leukemia/lymphoma 2 | Mus musculus |
| 2 | BCL2 activation in mouse Emu-myc lymphomas antagonized tigecycline-induced cell death, which was specifically restored by combined treatment with the BCL2 inhibitor venetoclax. | venetoclax | B cell leukemia/lymphoma 2 | Mus musculus |
| 3 | BCL2 activation in mouse Emu-myc lymphomas antagonized tigecycline-induced cell death, which was specifically restored by combined treatment with the BCL2 inhibitor venetoclax. | venetoclax | B cell leukemia/lymphoma 2 | Mus musculus |